OncoSil Medical Limited announced the appointment of Ms. Lel Smits as a Non- Executive Director to the Board of OncoSil Medical, effective immediately. Ms. Smits brings a wealth of expertise in governance, strategy, risk oversight, and corporate communications, with a distinguished career advising over 500 ASX-listed management teams and Boards. Ms. Smits is an award-winning entrepreneur and director, recognised as Director of the Year by Women in Finance in both 2024 and 2022.
Since 2021, she has served as a Director on the Board of Australian Shareholders' Association. Her extensive career began as a finance journalist, including roles as a foreign correspondent in New York, reporting from inside the New York Stock Exchange on Wall Street. With deep experience in the financial markets and corporate affairs, Ms. Smits has contributed significantly to entrepreneurial ventures and Boards, enhancing their governance and strategic direction.
She holds formal qualifications including a Master of Arts in Journalism from the University of Technology, Sydney (UTS), a Diploma of Investor Relations from the Australasian Investor Relations Association (AIRA) and is a graduate of the Australian Institute of Company Directors' (AICD) Company Directors Course.
